Cogent Biosciences COGT
NASDAQ COGT
$31.22 -0.21 (-0.67%)
As of: Oct 22, 2026 · 11:26 AM EDT

Cogent Biosciences (COGT) Interest Expenses (2025 - 2026)

Updated

Cogent Biosciences (COGT) recorded Interest Expenses of $1.22 million in Q2 2026, up 287.6% from $314,000 a year earlier and up 0.3% from the prior quarter.

Analysis

Cogent Biosciences (COGT) Interest Expenses (2025 - 2026) Analysis & Trends

On a TTM basis, Cogent Biosciences' Interest Expenses came in at $5.18 million as of Jun 30, 2026; for FY2025, it was $3.06 million.

  • Quarterly Interest Expenses has ranged from $314,000 in Q2 2025 to $1.46 million in Q3 2025 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $1.21 million (Q1 2026), $1.29 million (Q4 2025) and $1.46 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,175.94 Bn 1,144.53 Bn 19.71 Bn -
2 Johnson & Johnson 638.47 Bn 556.99 Bn 17.26 Bn 281.00 Mn
3 AbbVie 504.39 Bn 477.51 Bn 12.70 Bn -
4 Merck 377.60 Bn 331.98 Bn 12.21 Bn -
5 Novartis Ag 304.31 Bn 268.30 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 267.64 Bn 241.32 Bn 12.86 Bn 435.00 Mn
7 Amgen 242.06 Bn 197.45 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 193.83 Bn 168.03 Bn 6.22 Bn 247.00 Mn
9 Pfizer 172.62 Bn 119.27 Bn 10.94 Bn -
10 Cogent Biosciences 5.35 Bn 2.40 Bn - 1.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.22 Mn
Mar 31, 2026 1.21 Mn
Dec 31, 2025 1.29 Mn
Sep 30, 2025 1.46 Mn
Jun 30, 2025 314,000.00
API Access

Cogent Biosciences Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=COGT&period=max&api_key=YOUR_API_KEY